alectinib

Italy

Drugs containing this active substance

  • ALECENSA

    It is used for the treatment of adults with a type of lung cancer called 'non-small cell lung cancer' (NSCLC) that is 'ALK-positive'. It can be prescribed after surgical removal of the tumor or as initial treatment for cancer that has spread to other parts of the body, or if the drug crizotinib has already been used.

    Form: capsules, hard gelatin

    Active substance Dosage
    alectinib -

    ATC: L01ED03

    Manufacturer: ROCHE REGISTRATION GMBH